BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2895033)

  • 1. The comparative pharmacology of the behavioral syndromes induced by TRH and by 5-HT in the rat.
    Pranzatelli MR
    Gen Pharmacol; 1988; 19(2):205-11. PubMed ID: 2895033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine-induced shaking behavior in the rat: structure-activity and relation to serotonin and benzodiazepine receptors.
    Pranzatelli MR
    Exp Neurol; 1989 Jun; 104(3):241-50. PubMed ID: 2542077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional significance of neonatal 5,7-dihydroxytryptamine lesions in the rat: response to selective 5-HT1A and 5-HT2,1C agonists.
    Pranzatelli MR; Dollison AM; Huang YY
    Brain Res Bull; 1990 Jun; 24(6):747-53. PubMed ID: 2142615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat.
    Pranzatelli MR; Pluchino RS
    Pharmacol Biochem Behav; 1991 Jun; 39(2):407-13. PubMed ID: 1835098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.
    Fone KC; Robinson AJ; Marsden CA
    Br J Pharmacol; 1991 Jun; 103(2):1547-55. PubMed ID: 1832068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
    Berendsen HH; Broekkamp CL
    Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
    Backus LI; Sharp T; Grahame-Smith DG
    Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of cerebellar Purkinje cells to serotonin and the 5-HT1A agonists 8-OH-DPAT and ipsapirone in vitro.
    Darrow EJ; Strahlendorf HK; Strahlendorf JC
    Eur J Pharmacol; 1990 Jan; 175(2):145-53. PubMed ID: 1968842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.
    Smith LM; Peroutka SJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1513-9. PubMed ID: 2942947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
    Pranzatelli MR; Huang YY; Dollison AM; Stanley M
    Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats.
    Goodwin GM; De Souza RJ; Green AR
    Psychopharmacology (Berl); 1986; 89(3):382-7. PubMed ID: 2941817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A and 5-HT2 receptors mediate discrete behaviors in the Mongolian gerbil.
    Eison AS; Wright RN
    Pharmacol Biochem Behav; 1992 Sep; 43(1):131-7. PubMed ID: 1409796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; AssiƩ MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
    De Souza RJ; Goodwin GM; Green AR; Heal DJ
    Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.